| 000 | 01358 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513103553.0 | ||
| 264 | 0 | _c19961127 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1093/infdis/174.5.1085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMdluli, K | |
| 245 | 0 | 0 |
_aBiochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cNov 1996 |
||
| 300 |
_a1085-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aIsoniazid _xmetabolism |
| 650 | 0 | 4 |
_aLipids _xbiosynthesis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aOxidoreductases |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 700 | 1 | _aSherman, D R | |
| 700 | 1 | _aHickey, M J | |
| 700 | 1 | _aKreiswirth, B N | |
| 700 | 1 | _aMorris, S | |
| 700 | 1 | _aStover, C K | |
| 700 | 1 | _aBarry, C E | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 174 _gno. 5 _gp. 1085-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/174.5.1085 _zAvailable from publisher's website |
| 999 |
_c8889105 _d8889105 |
||